Nicht an der Qualität sparen. Mit Anlagelösungen der Landesbank Baden-Württemberg. Jetzt mehr erfahren -Werbung-
08.01.2024 14:38:23

Surgery Partners Backs Annual Revenue Guidance In Line With Estimates

(RTTNews) - Surgery Partners, Inc. (SGRY), a short-stay surgical facility owner and operator, on Monday reaffirmed its full-year guidance revenue outlook in line with the Street view.

For the full year, excluding items, the company still expects EBITDA of $436 million to $440 million.

Surgery Partners continues to expect annual revenue of around $2.75 billion.

On average, 10 analysts polled by Thomson Reuters expect SGRY to register revenue of $2.75 billion, for the year. Analysts' estimates typically exclude special items.

For the full year 2024, consistent with its commitment to drive mid-teens growth, the company projects an adjusted EBITDA of over $495 million.

SGRY was trading down by 0.19 percent at $31 per share in the pre-market trade on the Nasdaq.

Analysen zu Surgery Partners Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Surgery Partners Inc 21,20 2,91% Surgery Partners Inc